The Pharmacology of Lymphocytes

  • Michael A. Bray
  • John Morley

Part of the Handbook of Experimental Pharmacology book series (HEP, volume 85)

Table of contents

  1. Front Matter
    Pages I-XXII
  2. Glossary of Common Immunological Terms

    1. Michael A. Bray, John Morley
      Pages 1-8
  3. Part 1

    1. Front Matter
      Pages 9-9
    2. J. M. Williams, T. B. Strom
      Pages 37-52
    3. J. T. Ransom, J. C. Cambier
      Pages 53-82
  4. Part 2

    1. Front Matter
      Pages 139-139
    2. H. F. J. Savelkoul, S. S. Pathak, N. R. Sabbele, R. Benner
      Pages 141-185
    3. B. M. Stadler, K. Hirai, J.-F. Gauchat
      Pages 235-253
    4. S. S. Alkan
      Pages 255-274
    5. C. Gaveriaux, T. Payne, F. Loor
      Pages 275-290
    6. M. J. H. Ratcliffe, J. R. Lamb
      Pages 319-343
    7. S. C. Gilman, R. T. Maguire, A. J. Lewis
      Pages 345-360
  5. Part 3

    1. Front Matter
      Pages 361-361
    2. M. M. Khan, K. L. Melmon
      Pages 363-383
    3. M. J. Parnham, W. Englberger
      Pages 385-414
    4. J.-F. Bach, M. Dardenne
      Pages 415-421
  6. Part 4

    1. Front Matter
      Pages 423-423
    2. T. W. Behrens, J. S. Goodwin
      Pages 425-439
    3. P. E. Lipsky
      Pages 441-452
    4. R. R. Bartlett
      Pages 453-469
    5. Y. Shiokawa
      Pages 471-486
    6. M. Parant, L. Chedid
      Pages 503-516
    7. G. Wolberg
      Pages 517-533
    8. H. Takada, J. Hamuro, S. Kotani
      Pages 555-575
  7. Back Matter
    Pages 611-628

About this book


"Immunopharmacology" , why not "pharmacoimmunology"? Professor H. O. Schild University College London, 1962 An intact immune response is essential for survival, as is evidenced by the various innate immune deficiency syndromes and by the emergence of the acquired immune deficiency syndrome (AIDS) as a pandemic during the last decade. Substances which stimulate the immune response might contribute to the therapy of AIDS and its precursor, AIDS-related syndrome, as well as of other clinical conditions in which immune responses can be diminished, such as carcinoma and infections. In other circumstances, an intact or heightened immune response may pose clinical problems; hence there is need to suppress, or diminish, components of the immune response. For instance, it is necessary to impair cellular immunity in order to ensure lasting acceptance of heterografts and it is already established that agents effective in transplantation are therapeutically effective in an range of autoimmune diseases. More recently, experimental studies have indicated that aberrant manifestations of humoral immunity, as in allergies, may also be amenable to pharmacological intervention.


biochemistry immunology immunotherapy lymphocytes pharmacology

Editors and affiliations

  • Michael A. Bray
    • 1
  • John Morley
    • 2
  1. 1.Research DepartmentCIBA-GEIGY AGBaselSwitzerland
  2. 2.Pharmaceutical Division, Preclinical ResearchSANDOZ Ltd.BaselSwitzerland

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag Berlin Heidelberg 1988
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-642-73219-5
  • Online ISBN 978-3-642-73217-1
  • Series Print ISSN 0171-2004
  • Series Online ISSN 1865-0325
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals
Pharmacology & Toxicology
Consumer Packaged Goods